Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 73-84 of 2,031
Behavioral study icon
RecruitingNCT05051618

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

This study is looking at whether POWER-MS can help people with Multiple Sclerosis or depression. Participants take part in POWER-MS and complete follow-up assessments.

In Chicago
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Depression
Drug study icon
RecruitingISRCTN14516822

Home-based transcranial direct current stimulation for major depressive disorder

This study is testing a medication approach for people with depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 100 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression
Behavioral study icon
RecruitingNCT06454695

Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery

This study is looking at whether questionnaires and follow-up can help people with depression, Mental Imagery, or Cognitive Behavioral Therapy. Participants take part in the program and complete follow-up questionnaires or assessments.

In Amsterdam
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition
Depression
Other study type icon
RecruitingNCT05441969

In Vivo Cortical Excitability Modulation in Major Depressive Disorder

This observational study is following people with depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Lisbon
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Portugal
Sponsor
Fundacao Champalimaud
Condition
Depression
Drug study icon
RecruitingNCT05644301

INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder

This study is comparing Celecoxib with placebo for people with depression or Inflammation. Participants receive Celecoxib or placebo and complete study visits and assessments.

Multiple locations, including Duffel
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Belgium
Sponsor
Universiteit Antwerpen
Condition
Depression
Drug study icon
RecruitingNCT05603104

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Depression in bipolarity After a First-time Treatment Failure

This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders, depression, or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Ramat Gan
Why is this study shown?

This study is directly about Depression.

Depression, Bipolarity, ...DrugFrom 18 Years to 70 Years
Countries
Israel
Sponsor
Dr. Inge Winter
Condition
Depression, Bipolarity, ...
Drug study icon
RecruitingNCT07462013

Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice

This study is looking at whether Soybean oil (Standard treatment) can help people with depression. Participants take part in Soybean oil (Standard treatment) and complete follow-up assessments.

In Taichung
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 50 Years to 80 Years
Countries
Taiwan
Sponsor
National Science and Technology Council, Taiwan
Condition
Depression
Biological study icon
RecruitingNCT04751331

Neural Response to Inflammatory Challenge in Major Depressive Disorder

This study is comparing LPS with placebo for people with depression. Participants receive LPS or placebo and complete study visits and assessments.

In Tulsa
Why is this study shown?

This study is directly about Depression.

DepressionBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT06695767

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

This study is looking at whether Neurobehavioral therapy can help people with depression or Epilepsy. Participants take part in Neurobehavioral therapy and complete follow-up assessments.

In Houston
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
Drug study icon
RecruitingNCT03065335

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

This study is comparing Ketamine with placebo for people with depression. Participants receive Ketamine or placebo and complete study visits and assessments.

In Bethesda
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Drug study icon
RecruitingNCT05136755

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

This study is looking at examine the efficacy and safety of an NMDA enhancer (NMDAE) in the treatment of antidepressant nonresponders with depression for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Taichung
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Depression
Drug study icon
RecruitingNCT04637620

NMDA Modulation in Major Depressive Disorder

This study is comparing NMDAE with placebo for people with depression. Participants receive NMDAE or placebo and complete study visits and assessments.

In Taichung
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 55 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.